- Home
- PRTG vs DRCT Comparison
PRTG vs DRCT Comparison
Compare PRTG & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTG
- DRCT
- Stock Information
- Founded
- PRTG 1973
- DRCT 2018
- Country
- PRTG British Virgin Islands
- DRCT United States
- Employees
- PRTG N/A
- DRCT N/A
- Industry
- PRTG Oil & Gas Production
- DRCT Computer Software: Programming Data Processing
- Sector
- PRTG Energy
- DRCT Technology
- Exchange
- PRTG Nasdaq
- DRCT Nasdaq
- Market Cap
- PRTG 17.7M
- DRCT 16.7M
- IPO Year
- PRTG N/A
- DRCT 2022
- Fundamental
- Price
- PRTG $8.41
- DRCT $0.55
- Analyst Decision
- PRTG
- DRCT Strong Buy
- Analyst Count
- PRTG 0
- DRCT 1
- Target Price
- PRTG N/A
- DRCT $6.00
- AVG Volume (30 Days)
- PRTG 30.8K
- DRCT 495.5K
- Earning Date
- PRTG 06-17-2025
- DRCT 05-06-2025
- Dividend Yield
- PRTG N/A
- DRCT N/A
- EPS Growth
- PRTG N/A
- DRCT N/A
- EPS
- PRTG N/A
- DRCT N/A
- Revenue
- PRTG N/A
- DRCT $48,170,000.00
- Revenue This Year
- PRTG N/A
- DRCT $51.78
- Revenue Next Year
- PRTG N/A
- DRCT $25.42
- P/E Ratio
- PRTG N/A
- DRCT N/A
- Revenue Growth
- PRTG N/A
- DRCT N/A
- 52 Week Low
- PRTG $2.10
- DRCT $0.44
- 52 Week High
- PRTG $23.01
- DRCT $6.59
- Technical
- Relative Strength Index (RSI)
- PRTG 52.50
- DRCT 47.87
- Support Level
- PRTG $7.51
- DRCT $0.50
- Resistance Level
- PRTG $8.77
- DRCT $0.57
- Average True Range (ATR)
- PRTG 0.64
- DRCT 0.05
- MACD
- PRTG 0.01
- DRCT 0.01
- Stochastic Oscillator
- PRTG 70.18
- DRCT 63.97
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.